Functional studies of these mutations reveal that gain-of-function mutations in NLRP1 increase susceptibility to skin cancer, and a unique regulatory auto-inhibition mechanism in the NLRP1 inflammasome. The gene discussed is NLRP1; the disease is skin neoplasm.